Zur Rose Group AG operates in the Drugs, proprietaries, and sundries sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Zur Rose Group AG with three other
drug stores in Europe:
Dermapharm Holding SE
sales of 572.42 million Euro [US$629.73 million]
of which 58%
was Pharmaceuticals and other products),
(1.55 billion Euro [US$1.71 billion]
of which 171%
was Services), and
Udg Healthcare Plc
based in Ireland
(1.10 billion Euro [US$1.22 billion]
of which 70%
Zur Rose Group AG reported sales of 1.21 billion Swiss Francs (US$1.22 billion)
December of 2018.
increase of 22.8%
versus 2017, when the company's sales were 982.92 million Swiss Francs.
This was the third consecutive year of growth at Zur Rose Group AG.
Sales of Germany saw an increase
38.9% in 2018, from
483.17 million Swiss Francs to 671.25 million Swiss Francs.